Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Mol Psychiatry ; 21(12): 1752-1767, 2016 12.
Article de Anglais | MEDLINE | ID: mdl-26809838

RÉSUMÉ

Recombinant human erythropoietin (EPO) improves cognitive performance in neuropsychiatric diseases ranging from schizophrenia and multiple sclerosis to major depression and bipolar disease. This consistent EPO effect on cognition is independent of its role in hematopoiesis. The cellular mechanisms of action in brain, however, have remained unclear. Here we studied healthy young mice and observed that 3-week EPO administration was associated with an increased number of pyramidal neurons and oligodendrocytes in the hippocampus of ~20%. Under constant cognitive challenge, neuron numbers remained elevated until >6 months of age. Surprisingly, this increase occurred in absence of altered cell proliferation or apoptosis. After feeding a 15N-leucine diet, we used nanoscopic secondary ion mass spectrometry, and found that in EPO-treated mice, an equivalent number of neurons was defined by elevated 15N-leucine incorporation. In EPO-treated NG2-Cre-ERT2 mice, we confirmed enhanced differentiation of preexisting oligodendrocyte precursors in the absence of elevated DNA synthesis. A corresponding analysis of the neuronal lineage awaits the identification of suitable neuronal markers. In cultured neurospheres, EPO reduced Sox9 and stimulated miR124, associated with advanced neuronal differentiation. We are discussing a resulting working model in which EPO drives the differentiation of non-dividing precursors in both (NG2+) oligodendroglial and neuronal lineages. As endogenous EPO expression is induced by brain injury, such a mechanism of adult neurogenesis may be relevant for central nervous system regeneration.


Sujet(s)
Érythropoïétine/métabolisme , Neurogenèse/effets des médicaments et des substances chimiques , Oligodendroglie/effets des médicaments et des substances chimiques , Animaux , Encéphale/métabolisme , Différenciation cellulaire/effets des médicaments et des substances chimiques , Différenciation cellulaire/physiologie , Système nerveux central/métabolisme , Cognition/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/physiologie , Mâle , Souris , Souris de lignée C57BL , Neurogenèse/physiologie , Neurones/métabolisme , Oligodendroglie/métabolisme , Cellules pyramidales/effets des médicaments et des substances chimiques , Cellules pyramidales/métabolisme , Protéines recombinantes/métabolisme
2.
Phys Med Biol ; 50(21): 5127-39, 2005 Nov 07.
Article de Anglais | MEDLINE | ID: mdl-16237245

RÉSUMÉ

An external local ultrasound (US) system was developed to induce controlled hyperthermia of subcutaneously implanted tumours in small animals (e.g., mice and rats). It was designed to be compatible with a small animal positron emission tomography scanner (microPET) to facilitate studies of hyperthermia-induced tumour re-oxygenation using a PET radiopharmaceutical, but it is applicable for any small animal study requiring controlled heating. The system consists of an acrylic applicator bed with up to four independent 5 MHz planar disc US transducers of 1 cm in diameter, a four-channel radiofrequency (RF) generator, a multiple thermocouple thermometry unit, and a personal computer with custom monitoring and controlling software. Although the system presented here was developed to target tumours of up to 1 cm in diameter, the applicator design allows for different piezoelectric transducers to be exchanged and operated within the 3.5-6.5 MHz band to target different tumour sizes. Temperature feedback control software was developed on the basis of a proportional-integral-derivative (PID) approach when the measured temperatures were within a selectable temperature band about the target temperature. Outside this band, an on/off control action was applied. Perfused tissue-mimicking phantom experiments were performed to determine optimum controller gain constants, which were later employed successfully in animal experiments. The performance of the SAHUS (small animal hyperthermia ultrasound system) was tested using several tumour types grown in thighs of female nude (nu/nu) mice. To date, the system has successfully treated 83 tumours to target temperatures in the range of 41-43 degrees C for periods of 65 min on average.


Sujet(s)
Hyperthermie provoquée , Tumeurs expérimentales/thérapie , Thermographie/méthodes , Échographie interventionnelle/méthodes , Algorithmes , Animaux , Température du corps , Lignée cellulaire tumorale , Modèles animaux de maladie humaine , Femelle , Température élevée , Humains , Souris , Souris nude , Transplantation tumorale , Tumeurs/métabolisme , Oxygène/métabolisme , Fantômes en imagerie , Tomographie par émission de positons , Ondes hertziennes , Logiciel , Température , Thermomètres , Facteurs temps
3.
Int J Hyperthermia ; 21(3): 271-81, 2005 May.
Article de Anglais | MEDLINE | ID: mdl-16019853

RÉSUMÉ

The response of xenotransplants were compared with waterbath immersion vs focal ultrasound (US) hyperthermia using tumour growth delay, immunhistochemistry and histopathology assays. Waterbath hyperthermia was performed by limb immersion. Precautions were taken to minimize total body heating by surrounding the mouse with plastic insulators. Thermometry was performed with clinical-grade, 20-gauge needle thermocouples and monitored with a Labthermics unit. Significant differences in cytotoxicity between ultrasound and waterbath treatment of tumors at 43 degrees C were observed as determined by TUNNEL assay. Conversely, contralateral (non-treated) tumours in animals treated with similar temperature demonstrated no significant differences between modalities. Western blot analysis revealed increased hsp70 induction at 43 degrees C in waterbath vs focal ultrasound hyperthermia. Comparison of tumour growth delay between tumours heated with waterbath vs ultrasound at 43 degrees C but not at 41 degrees C revealed significant differences. This is the first study comparing localized vs regional hyperthermia using the small animal ultrasound system (SAHUS) delivery system. Consistent ultrasound hyperthermia can be achieved throughout a xenotransplant. At equivalent temperature of 43 degrees C for 60?min, waterbath hyperthermia demonstrated greater local response vs ultrasound hyperthermia.


Sujet(s)
Hyperthermie provoquée/méthodes , Tumeurs expérimentales/thérapie , Ultrasonothérapie , Animaux , Femelle , Membre thoracique , Cellules HeLa , Membre pelvien , Humains , Méthode TUNEL , Souris , Souris nude , Tumeurs expérimentales/anatomopathologie , Charge tumorale , Tests d'activité antitumorale sur modèle de xénogreffe
4.
Int J Hyperthermia ; 20(1): 32-44, 2004 Feb.
Article de Anglais | MEDLINE | ID: mdl-14612312

RÉSUMÉ

An external ultrasound system was developed for the heating of subcutaneously implanted tumours in small animals. This small animal hyperthermia ultrasound system (SAHUS) was designed to be compatible with a microPET (small animal positron emission tomography) scanner to facilitate studies of hyperthermia effects on tumour hypoxia. Collimation and localization of energy deposition, a specific goal for the new device to avoid regional and/or systemic heating of small animals, was demonstrated using thermoradiography following high-power short-time heating of a layered gel phantom. The in vivo heating capabilities of the SAHUS were tested using PC3 cell line tumours (2000-2700 mm(3)) grown in the lateral proximal thighs of Nu-/Nu- nuBR nude mice. Intratumour temperatures were recorded during heating trials with deep and superficial interstitial thermocouples. The experimental data showed that the SAHUS could produce hyperthermia in 8 +/- 2 mm diameter tumours in small animals to a target temperature of 41.5 degrees C and maintain it within a narrow temperature range (+/- 0.3 degrees C) for up to 4 h without raising the core temperature of the animals. PET imaging studies, data to be published separately, were conducted before and during SAHUS-induced hyperthermia. Both devices performed as expected and there was no significant decrease in image quality. In this paper, the new SAHUS is described and data from phantom and in vivo experiments presented.


Sujet(s)
Hyperthermie provoquée/instrumentation , Tumeurs expérimentales/thérapie , Ultrasonothérapie/instrumentation , Résines acryliques/composition chimique , Algorithmes , Animaux , Température du corps , Lignée cellulaire tumorale , Hyperthermie provoquée/méthodes , Souris , Souris nude , Tissu sous-cutané/anatomopathologie , Thérapie assistée par ordinateur , Thermographie , Cuisse/anatomopathologie , Tomoscintigraphie/instrumentation , Ultrasonothérapie/méthodes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...